胚系DDX41突变定义了一种独特的髓系肿瘤亚型
该研究纳入9082例髓系肿瘤患者中的346例DDX41致病/可能致病胚系变异和/或体细胞突变患者及525例一级亲属,发现胚系DDX41变异解释约80%的成人已知胚系易感髓系肿瘤,风险等位基因在男性中富集更明显(20.7 vs 5.0),40岁前发病风险可忽略但90岁时升至49%,且DDX41突变MDS进展为AML仅限于截短变异者。
要点
- 胚系DDX41变异解释约80%的成人已知胚系易感髓系肿瘤。
- DDX41风险等位基因在男性中富集更明显(20.7 vs 5.0)。
- DDX41突变MDS进展为AML仅限于截短变异者。
核心结论
- 伴DDX41突变的MDS定义了不同于其他髓系肿瘤的独特亚型。
研究设计与样本
- 研究纳入9082例髓系肿瘤患者中的346例DDX41致病/可能致病胚系变异和/或体细胞突变患者,以及525例DDX41突变和野生型患者的一级亲属。
主要发现
- 胚系DDX41致病/可能致病变异解释约80%的成人已知胚系易感髓系肿瘤。
- 这些风险变异在日本髓系肿瘤病例(n=4461)中较日本一般人群(n=20238)富集10倍。
- DDX41风险等位基因富集在男性(20.7)比女性(5.0)更明显。
- 致病/可能致病DDX41变异赋予髓系肿瘤大风险,40岁前可忽略但90岁时迅速升至49%。
- 伴DDX41突变的MDS患者 rapid 进展为AML,但仅限于截短变异者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Germ line DDX41 variants have been implicated in late-onset myeloid neoplasms (MNs). Despite an increasing number of publications, many important features of DDX41-mutated MNs remain to be elucidated. Here we performed a comprehensive characterization of DDX41-mutated MNs, enrolling a total of 346 patients with DDX41 pathogenic/likely-pathogenic (P/LP) germ line variants and/or somatic mutations from 9082 MN patients, together with 525 first-degree relatives of DDX41-mutated and wild-type (WT) patients. P/LP DDX41 germ line variants explained ∼80% of known germ line predisposition to MNs in adults. These risk variants were 10-fold more enriched in Japanese MN cases (n = 4461) compared with the general population of Japan (n = 20 238). This enrichment of DDX41 risk alleles was much more prominent in male than female (20.7 vs 5.0). P/LP DDX41 variants conferred a large risk of developing MNs, which was negligible until 40 years of age but rapidly increased to 49% by 90 years of age. Patients with myelodysplastic syndromes (MDS) along with a DDX41-mutation rapidly progressed to acute myeloid leukemia (AML), which was however, confined to those having truncating variants. Comutation patterns at diagnosis and at progression to AML were substantially different between DDX41-mutated and WT cases, in which none of the comutations affected clinical outcomes. Even TP53 mutations made no exceptions and their dismal effect, including multihit allelic status, on survival was almost completely mitigated by the presence of DDX41 mutations. Finally, outcomes were not affected by the conventional risk stratifications including the revised/molecular International Prognostic Scoring System. Our findings establish that MDS with DDX41-mutation defines a unique subtype of MNs that is distinct from other MNs.
引用
- Makishima H, Saiki R, Nannya Y, et al. Germ line DDX41 mutations define a unique subtype of myeloid neoplasms. Blood. 2023. PMID: 36322930. doi:10.1182/blood.2022018221
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。